Connect with us

Business News

Can summer survive America’s coronavirus spike? – BBC News

Visitors have returned to US vacation spots like Cape Cod, but the virus casts a shadow.

Published

on

post featured image

Business News

Nikola Sells 2,500 Garbage Trucks. It’s Not the Badger, but It’s a Better Deal. – Barron’s

Published

on

post featured image

Nikola
shares were trading lower Tuesday, after a 22% bounce on Monday following the announcement of an order for 2,500 battery-powered trucks from waste hauler
Republic Services.Investors were hungry for customer traction, and they got it. Despite the stock giving back some of Mondays gains, Wall Street seems impressed with the deal. The order validates the company, Deutsche Bank analyst Emmanuel Rosner said in a Tuesday research report. He rates Nikola shares (ticker: NKLA) the equivalent …

Click here to view the original article.

Continue Reading

Business News

Dow up over 300 points as investors snap up beaten down stocks, S&P 500 nears all-time high – MarketWatch

Dow gains led by JPMorgan Chase, Amex and Boeing

Published

on

post featured image

Stocks rose Tuesday, with shares of cyclical companies continuing to outpace previously highflying tech stocks, while the S&P 500 approached its all-time closing high from February, nearly completing a round trip from its pandemic-induced plunge earlier this year.The Dow Jones Industrial Average
DJIA,
+0.73%
rose 305 points, or 1.1%, to 28,096, while the S&P 500
SPX,
+0.19%
advanced 16 points, or 0.5%, to 3,377. The tech-heavy Nasdaq Composite
COMP,
-0.50%
lagged the ot…

Click here to view the original article.

Continue Reading

Business News

Inovio shares tumble as analysts say COVID-19 vaccine update left more questions than answers – MarketWatch

Biotech’s loss widened and revenue fell short, while analysts are still keen for more data from Phase 1 vaccine trial

Published

on

post featured image

Inovio Pharmaceuticals Inc. shares tumbled 22% Tuesday, a day after the company reported a wider-than-expected second-quarter loss and offered a limited update on its COVID-19 vaccine candidate which is currently in clinical trials.The stock
INO
is still up 343% on the year after gaining early in the coronavirus pandemic on hopes for its vaccine candidate, INO-4800, one of many in trials around the world. Plymouth Meeting, Pennsylvania-based Inovio develops DNA based immunotherapies and vacci…

Click here to view the original article.

Continue Reading

Trending